# Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid

> **NCT05906706** · — · APPROVED_FOR_MARKETING · sponsor: **Regeneron Pharmaceuticals**

## Conditions studied

- Bullous Pemphigoid

## Interventions

- **DRUG:** dupilumab

## Key facts

- **NCT ID:** NCT05906706
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05906706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05906706, "Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05906706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*